CareDx Reports Q3 Revenue of $139.4 Million, Raises 2026 Guidance

CareDx reported adjusted EPS of $0.70 and a 51% year-over-year increase in testing volume. It now expects 2026 revenue of $520 million to $530 million and adjusted EBITDA of $90 million to $100 million.